UNSPSC 51263129: Oxprenolol

This classification denotes a beta-adrenergic blocking agent with the molecular formula C15H23NO3, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 519MXN9YZR, chemically known as 2-propanol, 1-(2-allyloxyphenoxy)-3-(isopropylamino)- but generally known as oxprenolol, which bears US NIH Compound Identifier 4631. European Medicines Agency schedules Oxprenolol in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB09555MIG.

UNSPSC 51263129 Oxprenolol is a Commodity code for a specific pharmaceutical product, but the recent state and local activity tagged under this code shows a significant mismatch. Seminole County, Florida posted an IFB in June 2026 for Naloxone and safe drug deactivation systems — opioid-antagonist emergency medications and disposal equipment, not oxprenolol (a beta-blocker used for hypertension and angina). The county seeks to procure 1,900 units of Naloxone and 800 safe drug deactivation systems annually through competitive bidding, with quarterly deliveries to the Seminole County Community Health Building in Sanford. This is the only recent opportunity present in the dataset under this code, and it represents community health and emergency-response infrastructure spending rather than the pharmaceutical product the code nominally describes.

The Seminole County solicitation (IFB 60459723LAS, response due July 26, 2023) requires vendors to include shipping and delivery costs, submit bids electronically through the county's e-Procurement Portal, comply with drug-free workplace and E-Verify requirements, and maintain workers' compensation, commercial general liability, and professional liability insurance. The contract structure includes an initial two-year term with an optional one-year renewal and a three-month probationary period allowing termination by the county without cause. The source indicates potential FEMA funding, which introduces Clean Air Act and Federal Water Pollution Control Act compliance obligations. The mismatch between the code's pharmaceutical scope and the actual procurement — which addresses opioid overdose response and controlled-substance disposal — suggests either a tagging error by Seminole County or that this code sees little relevant recent activity in state and local procurement.